Continuous glucose monitoring in pregnant women with type 1 diabetes

  title={Continuous glucose monitoring in pregnant women with type 1 diabetes},
  author={S. K. Garg and Sarit Polsky},
  journal={The Lancet},
The use of continuous glucose monitoring (CGM) has been increasing, especially in patients with type 1 diabetes, partly due to improved accuracy with lower mean amplitude relative difference (about 10%) with the newer or implantable sensors. Most real-time subcutaneous sensors are approved for 7 days—except for the implantable sensor, which lasts 3 months—and require two calibrations per day. One on-demand sensor is approved for 14 days and needs no calibrations. Improved health outcomes, such… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 3 times over the past 90 days. VIEW TWEETS
2 Citations
13 References
Similar Papers


Publications referenced by this paper.
Showing 1-10 of 13 references

Evaluation of a predictive lowglucose management system inclinic

  • BA Buckingham, TS Bailey, M Christiansen
  • Diabetes Technol Ther
  • 2017

The future of continuous glucose monitoring

  • Satish K Garg, SK Garg, HK Akturk
  • Diabetes Technol Ther
  • 2017

Similar Papers

Loading similar papers…